Phospho-STX1A (S14) Antibody

What is Syntaxin-1A and what role does phosphorylation at S14 play?

Syntaxin-1A (STX1A) is a critical protein encoded by the STX1A gene, functioning primarily in the regulation of synaptic vesicle exocytosis in neurons. The phosphorylation of STX1A at serine 14 (S14) is primarily mediated by casein kinase 2α (CK2α) . This specific phosphorylation event has been demonstrated to regulate pre-synaptic vesicle release, suggesting a role in both the priming of synaptic vesicles and their subsequent release mechanisms . Recent research indicates that STX1A regulates spontaneous neurotransmitter release through multiple distinct mechanisms, including through its SNARE domain and through interactions that may be modulated by this phosphorylation site .

What species reactivity can be expected with Phospho-STX1A (S14) antibodies?

Most commercially available Phospho-STX1A (S14) antibodies demonstrate reactivity across multiple mammalian species. Based on validation studies, these antibodies typically react with human, mouse, and rat samples . This cross-reactivity stems from the high conservation of the amino acid sequence surrounding the S14 phosphorylation site across these species. When selecting an antibody for your research, verify the specific reactivity profile of your chosen antibody, as some may have been more extensively validated in certain species than others.

What are the main applications for Phospho-STX1A (S14) antibodies?

Phospho-STX1A (S14) antibodies can be utilized in several experimental techniques:

Each application requires specific optimization for your experimental system, including proper controls to confirm specificity of the phosphorylation-state specific signal.

How does CK2α knockdown affect STX1A phosphorylation at S14 and what are the functional consequences?

Research has demonstrated that CK2α knockdown significantly reduces phosphorylation of STX1A at S14. In a study utilizing shRNA to knock down CK2α in cortical neurons, researchers observed approximately 60% reduction in CK2α protein levels, which resulted in a significant decrease in Ser14 phosphorylation of endogenous STX1A . Interestingly, knockdown of another kinase, CK1α, did not alter STX1A S14 phosphorylation despite achieving approximately 80% knockdown efficiency .

How can researchers distinguish between phosphorylated and non-phosphorylated forms of STX1A in experimental samples?

Distinguishing between phosphorylated and non-phosphorylated forms of STX1A requires several methodological approaches:

• Phospho-specific antibodies: Using antibodies that specifically recognize STX1A phosphorylated at S14 is the most direct approach. These antibodies bind only to the phosphorylated form of the protein .

• Phosphatase treatment controls: Treating sample aliquots with lambda phosphatase as a negative control can confirm the specificity of phospho-specific antibody signals. This treatment removes phosphate groups from proteins, eliminating true phospho-specific signals .

• Competition assays with phospho-peptides: As demonstrated in validation studies, pre-absorption of the antibody with the phospho-peptide immunogen can block specific binding in Western blot and immunofluorescence applications, providing evidence of phospho-specificity .

• Phospho-null mutants: Using S14A mutants as controls in overexpression studies can provide a reference for non-phosphorylated state detection .

In Western blot applications, researchers should note that phosphorylated STX1A may appear as a doublet, suggesting multiple phosphorylated isoforms of STX1 in rat neurons. Studies have shown that the lower band typically represents Stx-1a phosphorylated at Ser14 .

What is the relationship between STX1A S14 phosphorylation and its interaction with Munc18-1?

This finding is consistent with biochemical data indicating that the S14A mutation causes only a minor decrease in the affinity of STX1A for Munc18-1 . Furthermore, both S14A and S14E mutations efficiently restored neurotransmitter release parameters to wild-type levels in STX1A-null neurons, suggesting that modulation of the STX1A N-peptide–Munc18-1 interaction by S14 phosphorylation may not significantly alter STX1A function in neurotransmitter release at central synapses .

These findings suggest that while S14 phosphorylation may modulate the STX1A-Munc18-1 interaction, this modulation may not be critical for the core functions of STX1A in neurotransmitter release.

What are the optimal conditions for detecting phosphorylated STX1A in Western blot applications?

For optimal detection of phosphorylated STX1A via Western blot, researchers should consider the following protocol elements:

• Sample preparation: Extracts from brain tissue or neuronal cultures should be prepared in buffers containing phosphatase inhibitors to preserve the phosphorylation state. Typical protocols use PBS (137 mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4, 2 mM KH2PO4, 3 mM KCl, 0.1% (v/v) Tween-20, pH 7.4) .

• Blocking conditions: Use 5% (w/v) bovine serum albumin in PBS-T for blocking membranes (1 hour incubation) and for diluting antibodies .

• Primary antibody incubation: Incubate membranes with phospho-specific STX1A (S14) antibody at dilutions between 1:500-1:2000 for 1 hour at room temperature or overnight at 4°C .

• Secondary antibody: Use Horseradish peroxidase-conjugated secondary antibodies (typically at 1:10,000 dilution) for 50 minutes .

• Detection: Enhanced chemiluminescence systems are typically used for visualization.

• Controls: Include phosphatase-treated samples as negative controls and CK2α-stimulated samples as positive controls. The use of blocking peptides can also confirm specificity .

Researchers should note that phosphorylated STX1A often appears as a doublet in Western blots when using phospho-STX1A antibodies, particularly in rat neurons where both Stx-1a and Stx-1b isoforms may be present .

How can researchers quantify changes in STX1A phosphorylation levels across experimental conditions?

To accurately quantify changes in STX1A phosphorylation levels:

• Normalization strategy:

  • Normalize phospho-STX1A signal to total STX1A levels in parallel samples to account for changes in total protein expression .

  • For immunofluorescence applications, normalize phospho-STX1A intensity to a synaptic marker like Bassoon to account for changes in synapse number or size .

• Statistical analysis:

  • For comparing two groups where one is set to a predetermined value (e.g., 100% control), use a one-sample t-test .

  • For comparing two groups with variance, employ a Student's t-test .

  • For multiple groups, use one-way ANOVA followed by Tukey's post hoc test .

  • For non-normally distributed data, use Mann-Whitney test (two groups) or Kruskal-Wallis followed by Dunn's multiple comparisons test (three or more groups) .

• Data presentation:

  • Present quantified data as mean ± standard deviation (SD) .

  • For visualization of trends over time, plotted curves can be presented as mean ± standard error of the mean (SEM) .

• Experimental considerations:

  • For biochemical assays, n numbers should refer to independent cell culture preparations from different dissections .

  • For imaging studies, n numbers should represent the number of cells assayed per condition, from at least three independent cell culture preparations .

What controls should be included when using phospho-STX1A (S14) antibodies to ensure specificity?

When using phospho-STX1A (S14) antibodies, the following controls are essential to ensure specificity:

• Peptide competition assays: Pre-absorbing the antibody with the phosphorylated peptide immunogen should block specific binding. This technique has been demonstrated in Western blot, immunohistochemistry, and immunofluorescence applications .

• Phosphatase treatment: Treating samples with lambda phosphatase to remove phosphate groups should eliminate signal from phospho-specific antibodies .

• Genetic models:

  • Using CK2α knockdown samples where S14 phosphorylation is reduced .

  • Using STX1A-null neurons as negative controls .

  • Employing phospho-null mutants (S14A) to demonstrate specificity for the phosphorylated state .

• Loading controls: For Western blot, include housekeeping proteins such as GAPDH as loading controls .

• Cross-reactivity assessment: If studying specific STX1 isoforms, note that the S14 region is identical between STX1A and STX1B, so the antibody may detect both isoforms. Some studies have observed that CK2α knockdown specifically reduces the lower band in Western blots, which represents STX1A .

How does phosphorylation of STX1A at S14 influence synaptic vesicle release mechanisms?

The influence of STX1A S14 phosphorylation on synaptic vesicle release mechanisms appears complex and potentially context-dependent:

• CK2α-mediated regulation: Research has demonstrated that knockdown of CK2α, which reduces S14 phosphorylation, enhances pre-synaptic vesicle release as measured by Synaptophysin-pHluorin (SypHy) exocytosis assays. This suggests that phosphorylation at S14 may serve as a negative regulator of vesicular release .

• Contradictory evidence in central synapses: Studies examining phosphonull (S14A) and phosphomimetic (S14E) STX1A mutants found that both efficiently restored release parameters to wild-type levels in STX1A-null neurons. This suggests that modulation of S14 phosphorylation might not significantly alter neurotransmitter release in all central synaptic contexts .

• Potential mechanistic explanations:

  • S14 phosphorylation may affect the interaction between STX1A's N-peptide and Munc18-1, although this effect appears minor in terms of binding affinity .

  • The regulatory effect of S14 phosphorylation may be more pronounced in certain cell types or under specific physiological conditions.

  • There may be compensatory mechanisms in neurons that can overcome alterations in S14 phosphorylation status.

• Cell-type specificity: The effects of S14 phosphorylation may differ between central neurons and neuroendocrine cells, as some studies have proposed direct functions of STX1A S14 phosphorylation on vesicular release in both neuron and neuroendocrine cell models .

These findings collectively suggest that while S14 phosphorylation can modulate vesicular release mechanisms, its importance may vary depending on the cellular context and experimental system.

What methodological approaches can be used to study the functional consequences of STX1A S14 phosphorylation in neurons?

Several methodological approaches have been employed to study the functional consequences of STX1A S14 phosphorylation:

• Genetic manipulation approaches:

  • shRNA-mediated knockdown of CK2α to reduce endogenous S14 phosphorylation .

  • Expression of phosphomimetic (S14E) and phosphonull (S14A) mutants in STX1A-null neurons to directly assess the role of S14 phosphorylation .

  • Use of lentiviral vectors for efficient gene delivery in neuronal cultures .

• Functional assays:

  • Synaptophysin-pHluorin (SypHy) exocytosis assays to measure vesicular release dynamics. This technique uses pH-sensitive GFP fused to synaptophysin to monitor synaptic vesicle exocytosis and endocytosis .

  • Electrophysiological recordings to measure neurotransmitter release parameters, including spontaneous and evoked release events .

  • Analysis of readily releasable pool (RRP) and reserve pool (RP) dynamics through specific stimulation protocols .

• Imaging approaches:

  • Immunofluorescence analysis of STX1A and Munc18-1 levels at synapses, normalized to synaptic markers like Bassoon .

  • Live cell imaging to monitor protein trafficking and localization.

• Biochemical approaches:

  • Co-immunoprecipitation assays to assess protein-protein interactions between STX1A and binding partners such as Munc18-1 .

  • Western blotting with phospho-specific antibodies to monitor phosphorylation levels .

• Survival and morphological analyses:

  • Monitoring neuronal density and survival over time in cultures expressing wild-type or mutant STX1A .

  • Analysis of neuronal morphology and synapse formation.

These complementary approaches allow researchers to comprehensively assess how S14 phosphorylation affects STX1A function at multiple levels, from molecular interactions to physiological outputs.

What are common problems encountered when using phospho-STX1A (S14) antibodies and how can they be resolved?

Researchers may encounter several challenges when working with phospho-STX1A (S14) antibodies:

• High background signal:

  • Problem: Non-specific binding resulting in high background.

  • Solution: Optimize blocking conditions by testing different blocking agents (BSA vs. milk) and concentrations. For phospho-specific antibodies, 5% BSA in PBS-T is typically recommended . Increase washing duration and frequency. Consider using a more dilute primary antibody solution.

• Weak or absent signal:

  • Problem: Insufficient phosphorylated protein in samples.

  • Solution: Ensure proper phosphatase inhibitor cocktails are included in all buffers during sample preparation. Consider enriching for phosphorylated proteins using phospho-protein enrichment kits. Validate the phosphorylation status using positive controls (e.g., brain lysates, which typically express phosphorylated STX1A) .

• Multiple bands or unexpected band patterns:

  • Problem: Detection of multiple phosphorylated isoforms or non-specific binding.

  • Solution: Note that phosphorylated STX1A may appear as a doublet in rat neurons, with the lower band representing STX1A . Use blocking peptide competition assays to confirm specificity . Include phosphatase-treated samples as negative controls.

• Variability between experiments:

  • Problem: Inconsistent results across replicate experiments.

  • Solution: Standardize sample preparation protocols, including consistent lysis methods and phosphatase inhibitor use. Prepare aliquots of antibody working solutions to ensure consistent concentrations. Include internal reference samples across blots for normalization.

• Difficulty distinguishing between STX1A and STX1B isoforms:

  • Problem: The S14 region is identical between STX1A and STX1B.

  • Solution: Consider using isoform-specific antibodies in parallel. Note that in some experimental systems, the lower band in a doublet typically represents STX1A .

How should researchers interpret conflicting results regarding the functional significance of STX1A S14 phosphorylation?

When faced with conflicting results regarding the functional significance of STX1A S14 phosphorylation, researchers should consider:

• Experimental context differences:

  • Cell type specificity: Effects may differ between central neurons, peripheral neurons, and neuroendocrine cells .

  • Developmental stage: The importance of phosphorylation may vary during development.

  • Activity state: Phosphorylation effects may be more pronounced under certain activity conditions.

• Methodological differences:

  • Knockdown vs. knockout approaches: shRNA-mediated knockdown of CK2α versus genetic manipulation of STX1A itself may yield different results .

  • Acute vs. chronic manipulations: Acute inhibition versus long-term genetic manipulation may allow for compensatory mechanisms.

  • Overexpression artifacts: Overexpression of mutant proteins may not accurately reflect the role of endogenous phosphorylation.

• Analysis framework:

  • Parameter selection: Different measures of synaptic function (spontaneous release, evoked release, vesicle pool dynamics) may be differentially affected .

  • Baseline normalization: Differences in how data is normalized and presented can lead to different interpretations.

• Reconciliation strategies:

  • Directly compare methodologies within a single study.

  • Perform more comprehensive analyses that capture multiple aspects of synaptic function.

  • Consider combinatorial approaches that manipulate multiple interactions simultaneously, as STX1A function involves multiple binding partners and conformational states .

• Biological redundancy:

  • Consider that there may be redundant or compensatory phosphorylation sites or mechanisms that maintain synaptic function even when S14 phosphorylation is altered.

What are the current knowledge gaps regarding phospho-STX1A (S14) and its role in neuronal function?

Despite significant research on STX1A S14 phosphorylation, several important knowledge gaps remain:

• Temporal dynamics of phosphorylation: Little is known about how S14 phosphorylation changes during neuronal activity, development, or in response to physiological stimuli.

• Cell-type specific functions: The role of S14 phosphorylation may vary across different neuronal types and brain regions, but systematic studies across diverse neuronal populations are lacking.

• Interplay with other post-translational modifications: STX1A undergoes multiple post-translational modifications, and the interplay between S14 phosphorylation and other modifications remains poorly understood.

• Pathophysiological relevance: The role of altered S14 phosphorylation in neurological disorders or under pathophysiological conditions requires further investigation.

• Upstream regulation of CK2α activity: While CK2α has been identified as the kinase responsible for S14 phosphorylation, the signaling pathways that regulate CK2α activity in neurons are not fully characterized.

• Molecular mechanisms of function: The precise molecular mechanisms by which S14 phosphorylation alters STX1A function, particularly its interactions with SNARE proteins and regulatory factors beyond Munc18-1, need further elucidation.